NASDAQ:CGTX | Free Cash Flow | COGNITION THERAPEUTICS INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$5.54M
2025-12-31-$3.44M
2025-03-31-$9.88M
2024-12-31-$8.38M$1,000.00-$8.38M
2024-03-31-$7.24M
2023-12-31-$5.46M$30,000.00-$5.49M
2023-03-31-$2.71M$41,000.00-$2.75M
2022-12-31-$10.18M$10,000.00-$10.19M
2022-03-31-$2.99M$134,000.00-$3.12M
2021-12-31$101,000.00
2021-03-31-$772,000.00
2020-12-31-$480,000.00$0.00-$480,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$24.59M
2024-12-31-$28.47M$4,000.00-$28.48M
2023-12-31-$16.02M$147,000.00-$16.17M
2022-12-31-$18.53M$171,000.00-$18.7M
2021-12-31-$3.63M$27,000.00-$3.66M
2020-12-31-$3.43M$10,000.00-$3.44M